	Adjuvant pressurized intraperitoneal aerosol chemotherapy (PIPAC) in suboptimally cytoreduced advanced ovarian cancer: a randomized phase II trial (PIPAC-OVA). BMC Cancer Dzasokhov AS, Khomyakov VM, Turiev AV, Astashov VL, Kostin AA, Gunyakov SO, Andreeva MA. PMID: 42243730 [PubMed - as supplied by publisher]
	An interpretable ultrasound-based deep learning system for early breast cancer in a Chinese population. Insights Imaging Wu S, Wang S, Liang D, Shi J, Shang X, Zhang L, Liu Y, Su X, Wang Y, Lu Q, Li Z, Zhao Z, Ji X, Li D, He Y. PMID: 42243600 [PubMed]
	Clinical and Pathological Characteristics and Prognosis of Breast Cancer During Pregnancy and Postpartum: A Multicenter Retrospective Study. Cancer Rep (Hoboken) Wang L, Deng H, Fang X, Li T, Chen Q, Liu J. PMID: 42243585 [PubMed - in process]
	Association of baseline tumor-infiltrating lymphocytes and cell-cycle regulation markers on prognosis and mortality in patients with advanced breast cancer according to tumor characteristics and treatment type: an observational study. Breast Cancer Res Treat Vuoti S, Saari M, Lahti J, Narasimha K, Reinikainen K. PMID: 42243565 [PubMed - in process]
	Post-neoadjuvant and peri-operative ctDNA-defined minimal residual disease in triple-negative breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat Barjij I, Naciri S, Lkhoyaali S, Kharmoum S, Inrhaouen H, Elghissassi I, Boutayeb S, Mrabti H, Errihani H. PMID: 42243561 [PubMed - in process]
	Retrospective study on regional nodal irradiation after omission of axillary lymph node dissection in sentinel lymph node-positive breast cancer: a propensity score matching analysis. Breast Cancer Res Treat Xia K, Tang N, Li D, Wang L, Xiao H. PMID: 42243510 [PubMed - in process]
	[State of the art and innovations in breast cancer prevention and screening strategies]. Bull Cancer Véron L, Balleyguier C, Lefeuvre-Plesse C, Fervers B, Joyon N, Caron O, Delaloge S. PMID: 42242965 [PubMed - as supplied by publisher]
	Shaping breast cancer progression in obesity: Insights from advanced models and omics tools. Biochim Biophys Acta Rev Cancer Emma R, Sergi V, Scordamaglia D, Scollo P, Clarke RB, Malaguarnera R, De Francesco EM. PMID: 42242589 [PubMed - as supplied by publisher]
	Metabolic crosstalk in breast cancer in patients with Type 2 diabetes mellitus: pathophysiology and nanotherapeutic opportunities for clinical translation. Diabetes Res Clin Pract Wakens A, Joseph D, Rambharose S. PMID: 42242553 [PubMed - as supplied by publisher]
	Tracking structural variants in early breast cancer using a high-sensitivity ctDNA assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial. ESMO Open Blaye C, Bidard FC, Hue L, Howarth K, Pierga JY, Dalenc F, Jacot W, Djerroudi L, Potonnier W, Dumas V, Lalet C, Maréchal M, Pulido M, Brunet M, Salabert L, Venat L, Maran-Gonzalez A, Saal LH, Franchet C, Birkeälv S, MacGrogan G, Bonnefoi H. PMID: 42242004 [PubMed - as supplied by publisher]
	EBCC-15 manifesto: Removing age-related barriers to improve equity in breast cancer care. Breast Poulakaki F, Brain E, Meattini I, Lambertini M, Pilleron S, Spanic T, Sardanelli F, Kalsi T, Kelly JE, Rubio IT, Cameron DA. PMID: 42241951 [PubMed - as supplied by publisher]
	Development and pilot feasibility of Kit-CAT, a serious-game-supported consultation for discussing complementary and alternative therapies in breast cancer care. Cancer Treat Res Commun Pinsault N, Girard P, Monvoisin R, Eychenne C, Genty-Vermorel C, Druart L. PMID: 42241921 [PubMed - as supplied by publisher]
	Erratum: VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer. J Clin Oncol Hurvitz SA, Layman RM, Curigliano G, André F, Cristofanilli M, Kim SB, Martínez Rodríguez JL, Nadal JC, Kim GM, Lo L, Remolina-Bonilla YA, Rosselli G, Emile G, Korbenfeld E, Puig JM, Wesolowski R, Martin M, Ring A, Han HS, Giordano A, Mutka SC, Moss K, Suzuki S, Sullivan B, Gorbatchevsky I, Pistilli B, VIKTORIA-1 Study Group. PMID: 42241670 [PubMed - as supplied by publisher]
	The Application of eHealth in Symptom Management of Patients With Breast Cancer During Endocrine Therapy: Scoping Literature Review. JMIR Cancer Gu C, Shen L, Zhang S, Zhang N. PMID: 42241587 [PubMed - in process]
	A multicenter, randomized, parallel-group confirmatory study protocol to evaluate the efficacy of Soft Protector CPC, a novel oral mucosal protectant, in preventing oral mucositis and alleviating pain in patients with breast cancer. PLoS One Omori K, Furukawa K, Usubuchi M, Hamada T, Shien T, Yoshida M, Nakatsuka Y, Hotta K, Ibaragi S, Takashiba S. PMID: 42241429 [PubMed - in process]
	Movement Disorders Associated With Breast Cancer: A Systematic Review. Ann Indian Acad Neurol Garg RK, Jain A, Agrawal AA, Pandey S, Suresh V, Singhal S. PMID: 42241181 [PubMed - as supplied by publisher]
	Erratum: A multimodal intelligent model for the noninvasive prediction of vascular endothelial growth factor expression and prognostic stratification in breast cancer: A multicenter retrospective study. J Cancer Res Ther PMID: 42241179 [PubMed - in process]
	Association between serum chemerin and breast cancer mediated by lipid metabolism. Discov Oncol Li H, Xu Q, Huang M, Shu J, Chen S, Xia J, Liu Y, Ye Y. PMID: 42240751 [PubMed - as supplied by publisher]
	Mammography screening in Tennessee: a tract-level spatial analysis of geographic and socioeconomic disparities. Cancer Causes Control Namin S, Wall JS, Heidel RE, Brooks A, Allen S, Ferris J. PMID: 42240725 [PubMed - indexed for MEDLINE]
	Integrative Chinese Herbal Medicine as Adjuvant Management for Triple-Negative Breast Cancer: A Multi-Institutional Real-World Study With Mechanism Exploration. Integr Cancer Ther Hou HI, Chou HH, Lee CW, Chen HY. PMID: 42240152 [PubMed - in process]

Articles 1 - 20 / 329662

Page 1 of 16484



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy